4
The mylife Aveo
™
blood glucose monitoring system is intended for in-vitro (outside the body) diagnostic use
for self-testing and used for the quantitative measurement of the glucose level as an aid in monitoring diabetes
management. The coding of the test strips is automatically detected. The test result is plasma equivalent
and achieved by using (a) fresh capillary whole blood that may be drawn from the fingertip (b) and venous whole
blood samples if drawn by healthcare professionals.
You may consult your healthcare professional for instructions on how to use the system correctly. Our customer
support staff are available to assist you. Healthcare professionals may use the mylife Aveo
™
blood glucose
monitoring system for surveillance of the blood glucose levels of patients in medical facilities.
For a better understanding of this user guide, the mylife Aveo
™
blood glucose monitoring system will be referred
to as BGMS; the mylife Aveo
™
blood glucose meter as meter; the mylife Aveo
™
Case as case; the mylife Aveo
™
test strips as test strips; the mylife Aveo
™
lancing device as lancing device; the mylife
™
Lancets as lancets;
the mylife Aveo
™
control solution as control solution; the mylife
™
App as app and the smartphone or personal
computer as mobile device.
Test principle: Glucose in blood samples reacts with the chemical reagent in the test strip to produce a small
electrical current. The mylife Aveo
™
meter detects this electrical current, which reflects the amount of glucose
in the blood sample.
Intendend use